However, accurate measurement of PD-L1 protein levels in FFPE tumor samples is hampered by technical issues, such as the use of different assays and antibodies across different studies and tumor types, the variability of cut-off values, and scoring methods and the lack of standardized methods (112). The gene discussed is CD274; the disease is neoplasm.